Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Food Sci Biotechnol ; 28(5): 1433-1438, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31695941

ABSTRACT

The optimum mixing ratio of red ginseng, herbal medicine extracts, and oligosaccharides for diabetic improvement was investigated and verified through animal experiments. Using the optimum mixing technique, 2% red ginseng extract, 15% oligosaccharides, and 83% herbal medicine extracts were determined to be optimal for red ginseng beverages. The taste was improved as the amount of red ginseng decreased and oligosaccharides increased, whereas antioxidative activity was increased with increased red ginseng. In the animal model in which streptozotocin was administered to BALB-c mice, the red ginseng administration group exhibited lower blood glucose than the diabetic control group, and the blood glucose level was lower in the herbal medicine and red ginseng extract administration group. Insulin concentration was slightly increased by the red ginseng beverage, and hepatotoxicity due to excessive intake of red ginseng beverages was not detected.

2.
Appl Biochem Biotechnol ; 185(2): 359-369, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29152694

ABSTRACT

Bacillus subtilis SC-8 (BSSC8) shows a narrow antimicrobial activity against the Bacillus cereus group. Previously, B. cereus-derived PapR as a signal peptide to stimulate PlcR, which plays a significant role in regulating the transcription of virulence factors, was assumed to stimulate antibiotic production in BSSC8. To better understand the functional role of PapR in the antibiotic production of BSSC8 and the interspecies interaction, the global transcriptomic profiling of BSSC8 was investigated using RNA-Seq in this study. Small peptides derived from B. cereus wild type (WTBC) and a papR-deleted mutant strain (MTBC) were individually supplied to BSSC8 cultures, and changes in global transcription levels were compared by RNA-Seq. In the presence of WTBC small peptides, more genes (80.9%) were significantly upregulated than in cells exposed to MTBC small peptides. Specifically, 48.8 and 83.4% of genes involved in glycolysis and the TCA cycle, respectively, showed changes in transcription levels in response to small peptides from both strains. Of the genes showing the alterations, 35.0% (glycolysis) and 60.0% (TCA cycle) of transcripts were significantly regulated only in response to WTBC-derived small peptides. Furthermore, the expression of biosynthetic genes encoding several known antibiotics in BSSC8 was further decreased in response to WTBC small peptides.


Subject(s)
Bacillus subtilis , Bacterial Proteins , Peptides , RNA, Bacterial , Sequence Analysis, RNA , Anti-Bacterial Agents/biosynthesis , Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Citric Acid Cycle/physiology , Glycolysis/physiology , Peptides/genetics , Peptides/metabolism , RNA, Bacterial/genetics , RNA, Bacterial/metabolism
3.
Can J Microbiol ; 61(2): 93-103, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25629960

ABSTRACT

The rapid onset of resistance reduces the efficacy of most conventional antimicrobial drugs and is a general cause of concern for human well-being. Thus, there is great demand for a continuous supply of novel antibiotics to combat this problem. Bacteria-derived antimicrobial peptides (AMPs) have long been used as food preservatives; moreover, prior to the development of conventional antibiotics, these AMPs served as an efficient source of antibiotics. Recently, peptides produced by members of the genus Bacillus were shown to have a broad spectrum of antimicrobial activity against pathogenic microbes. Bacillus-derived AMPs can be synthesized both ribosomally and nonribosomally and can be classified according to peptide biosynthesis, structure, and molecular weight. The precise mechanism of action of these AMPs is not yet clear; however, one proposed mechanism is that these AMPs kill bacteria by forming channels in and (or) disrupting the bacterial cell wall. Bacillus-derived AMPs have potential in the pharmaceutical industry, as well as the food and agricultural sectors. Here, we focus on Bacillus-derived AMPs as a novel alternative approach to antibacterial drug development. We also provide an overview of the biosynthesis, mechanisms of action, applications, and effectiveness of different AMPs produced by members of the Bacillus genus, including several recently identified novel AMPs.


Subject(s)
Antimicrobial Cationic Peptides/pharmacology , Bacillus/chemistry , Drug Resistance, Bacterial , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Chemistry, Pharmaceutical , Drug Design , Humans , Lipopeptides/chemistry , Peptides/chemistry , Ribosomes/chemistry
4.
Mol Neurobiol ; 49(3): 1400-21, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24430743

ABSTRACT

Ginsenoside Re, one of the main constituents of Panax ginseng, possesses novel antioxidant and anti-inflammatory properties. However, the pharmacological mechanism of ginsenoside Re in dopaminergic degeneration remains elusive. We suggested that protein kinase C (PKC) δ mediates methamphetamine (MA)-induced dopaminergic toxicity. Treatment with ginsenoside Re significantly attenuated methamphetamine-induced dopaminergic degeneration in vivo by inhibiting impaired enzymatic antioxidant systems, mitochondrial oxidative stress, mitochondrial translocation of protein kinase Cδ, mitochondrial dysfunction, pro-inflammatory microglial activation, and apoptosis. These protective effects were comparable to those observed with genetic inhibition of PKCδ in PKCδ knockout (-/-) mice and with PKCδ antisense oligonucleotides, and ginsenoside Re did not provide any additional protective effects in the presence of PKCδ inhibition. Our results suggest that PKCδ is a critical target for ginsenoside Re-mediated protective activity in response to dopaminergic degeneration induced by MA.


Subject(s)
Dopaminergic Neurons/drug effects , Ginsenosides/pharmacology , Methamphetamine/toxicity , Microglia/drug effects , Mitochondria/drug effects , Oxidative Stress/drug effects , Protein Kinase C-delta/antagonists & inhibitors , Animals , Dopaminergic Neurons/metabolism , Ginsenosides/chemistry , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microglia/metabolism , Mitochondria/metabolism , Nerve Degeneration/chemically induced , Nerve Degeneration/drug therapy , Nerve Degeneration/metabolism , Oxidative Stress/physiology , Protein Kinase C-delta/metabolism , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology
5.
Appl Biochem Biotechnol ; 172(2): 580-94, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24104687

ABSTRACT

Bacillus subtilis SC-8 produces an antibiotic that has narrow antagonistic activity against bacteria in the Bacillus cereus group. In B. cereus group bacteria, peptide-activating PlcR (PapR) plays a significant role in regulating the transcription of virulence factors. When B. subtilis SC-8 and B. cereus are co-cultured, PapR is assumed to stimulate antibiotic production by B. subtilis SC-8. To better understand the effect of PapR on this interspecies interaction, the global transcriptome profile of B. subtilis SC-8 was analyzed in the presence of PapR. Significant changes were detected in 12.8 % of the total transcripts. Genes related to amino acid transport and metabolism (16.5 %) and transcription (15 %) were mainly upregulated, whereas genes involved in carbohydrate transport and metabolism (12.7 %) were markedly downregulated. The expression of genes related to transcription, including several transcriptional regulators and proteins involved in tRNA biosynthesis, was increased. The expression levels of genes associated with several transport systems, such as antibiotic, cobalt, and iron complex transporters, was also significantly altered. Among the downregulated genes were transcripts associated with spore formation, the subtilosin A gene cluster, and nitrogen metabolism.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Bacillus subtilis/genetics , Bacterial Proteins/pharmacology , Protein Sorting Signals , Sequence Analysis, RNA , Amino Acids/biosynthesis , Bacillus subtilis/drug effects , Bacillus subtilis/physiology , Bacteriocins/biosynthesis , Biosynthetic Pathways/drug effects , Biosynthetic Pathways/genetics , Down-Regulation/drug effects , Down-Regulation/genetics , Gene Expression Profiling , Gene Expression Regulation, Bacterial/drug effects , Genes, Bacterial , Multigene Family , RNA, Bacterial/biosynthesis , RNA, Transfer/biosynthesis , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction , Spores, Bacterial/drug effects , Spores, Bacterial/genetics , Transcription Factors/metabolism , Up-Regulation/drug effects , Up-Regulation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...